* The goal of this clinical trial entitled, PrEP2Prevent: An Online PrEP Navigation and Activation Intervention for YMSM, is to develop and test a method for supporting access to an HIV prevention medication called Pre-Exposure Prophylaxis (PrEP) in young men who have sex with men and young transgender and non-binary individuals. The main questions it aims to answer are: * What are some of the experiences and barriers providers have seen regarding this population accessing PrEP * Using information gathered from PrEP providers and navigators, develop a mobile health platform and PrEP related content that will be tested by members of the population to see if the features are usable and the content is understandable. * Enroll 150 study participants to see if utilizing the mobile health platform and receiving supportive sessions related to motivation and barriers to accessing PrEP is achievable. * Participants will * Be given access to the mobile health Platform called PrEPresent, which provides them with access to prevention related content, the ability to schedule with a patient navigator and create customizable goals * Complete a baseline, 3 month and 6 month assessment about personal health, health history and technology, along with a PrEP adherence rapid urine test * Complete up to 4 sessions to assist participants in the intervention group with discussing any barriers to accessing PrEP
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Formative Research - PrEP Provider and Navigator Interviews
Timeframe: 90 minute one time interview
Formative Research - Youth Working Groups
Timeframe: 4 week duration
Pre-Pilot Mobile App Usability Testing
Timeframe: 4 week duration
Patient Navigation Feasibility
Timeframe: 6 Months
Patient Navigation Acceptability
Timeframe: 6 Months
PrEP Uptake
Timeframe: 6 Months